Multicenter phase II trial of topotecan, cisplatin and bevacizumab for recurrent or persistent cervical cancer

OBJECTIVE: We evaluated the activity and safety of the combination of topotecan, cisplatin and bevacizumab in patients with recurrent or persistent carcinoma of the cervix. METHODS: Eligible patients had persistent or recurrent cervical cancer not amenable to curative intent treatment. No prior chem...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Zighelboim, Israel, Wright, Jason D., Gao, Feng, Case, Ashley S., Massad, L. Stewart, Mutch, David G., Powell, Matthew A., Thaker, Premal H., Eisenhauer, Eric L., Cohn, David E., Valea, Fidel A., Secord, Angeles Alvarez, Lippmann, Lynne T., Dehdashti, Farrokh, Rader, Janet S.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2013
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3870479/
https://ncbi.nlm.nih.gov/pubmed/23591400
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2013.04.009
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller